Home
Storia in 1 fonti
LifeSci Capital Keeps Their Buy Rating on Immunome (IMNM)
In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Immunome, with a price target of $40.00.Claim 55% Off Ti...
Raccontata da
markets.businessinsider.com
- ·
LifeSci Capital Sticks to Their Buy Rating for MoonLake Immunotherapeutics (MLTX)
LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on MoonLake Immunotherapeutics today and set a price target of $33.00.Claim 55% Of...
- ·
LifeSci Capital Remains a Buy on Ibio (IBIO)
In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Ibio, with a price target of $5.00.Claim 55% Off Tip...
- ·
LifeSci Capital Keeps Their Buy Rating on Immunome (IMNM)
In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Immunome, with a price target of $40.00.Claim 55% Off Ti...
- ·
Immunic (IMUX) Gets a Buy from LifeSci Capital
In a report released yesterday, Sam Slutsky from LifeSci Capital maintained a Buy rating on Immunic, with a price target of $56.00.Claim 55% Off...